Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse

Journal of Comparative Neurology

Volumn 413, Issue 3, 1999, Pages 449-462

  Alonso Vanegas, Mario A ^a   Fawcett, James P ^a   Causing, Carrie G ^a   Miller, Freda D ^a   Sadikot, Abbas F ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Anterograde survival; Brain derived neurotrophic factor; Locus coeruleus; Neurotrophins; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE BETA MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; LOCUS CERULEUS; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, TRANSGENIC; NEURONS; PROMOTER REGIONS (GENETICS);

EID: 0033604316     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19991025)413:3<449::AID-CNE7>3.0.CO;2-2     Document Type: Article

References (115)

1. Abercombie M. 1946. Estimation of nuclear population from microtome sections. Anat Rec 94:239-247.
2. Alcántara S, Frisén J, del Rio JA, Soriano E, Barbacid M, Silos-Santiago I. 1997. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci 17:3623-3633.
3. Altar CA, DiStefano PS. 1998. Neurotrophin trafficking by anterograde transport. Trends Neurosci 21:433-437.
4. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89:11347-11351.
5. Altar CA, Boylan CB, Jackson C, Fritsche M, Jones BE, Wiegand SJ, Lindsay RM, Hyman C. 1994. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J Neurochem 63:1021-1032.
6. Aston-Jones G, Shipley MT, Grzanna R. 1995. The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G, editor. The rat nervous system. New York: Academic Press. p 183-213.
7. Bamji SX, Majdan M, Pozniak CD, Bellineau DJ, Aloyz R, Kohn J, Causing CG, Miller FD. 1998. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140:911-923.
8. Barde YA, Edgar D, Thoenen H. 1982. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549-553.
9. Bayer SA, Altman J, Russo RJ, Zhang X. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14:83-144.
10. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
11. Belliveau DJ, Krivko I, Kohn J, Lachance C, Pozniak C, Rusakov D, Kaplan D, Miller FD. 1997. NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulates survival and neurito-genesis. J Cell Biol 136:375-388.
12. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A. 1991. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7:857-866.
13. Bing G, Zhang Y, Watanabe Y, McEwen BS, Stone EA. 1994. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res 668:261-265.
14. Birling MC, Price J. 1995. Influence of growth factors on neuronal differentiation. Curr Opin Cell Biol 7:878-884.
15. Björklund A, Lindvall O. 1984. Dopamine containing systems in the CNS. In: Björklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy. Amsterdam: Elsevier. p 55-122.
16. Bothwell M. 1995. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223-253.
17. Causing CG, Gloster A, Aloyz R, Bamji SX, Chang E, Fawcett J, Kuchel G, Miller FD. 1997. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron 18:257-267.
18. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hokfelt T. 1991. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA 88:10352-10356.
19. Clarke PG, Oppenheim RW. 1995. Neuron death in vertebrate development: in vitro methods. Methods Cell Biol 46:277-321.
20. Coggeshall RE, Lekan HA. 1996. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364:6-15.
21. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. 1997. Distribution of brain-derived neurotrophic factor (BDNF) protein mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313.
22. Conover JC, Yancopoulos GD. 1997. Neurotrophin regulation of the developing nervous system: analysis of knockout mice. Rev Neurosci 8:13-27.
23. Conover JC, Erickson JT, Katz DM, Bianchi LM, Poueymirou WT, McClain J, Pan L, Helgren M, Ip NY, Boland P, Friedman B, Wiegand S, Vejsada R, Kato AC, DeChiara TM, Yancopoulos GD. 1995. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 375:235-238.
24. Coyle JT, Axelrod J. 1972. Tyrosine hydroxylase in rat brain: developmental characteristics. J Neurosci 19:1117-1123.
25. Dahlstrom A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62(Suppl 232):1-55.
26. Domesick VB, Stinus L, Paskevich PA. 1983. The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: a light-and electron-microscopic study. Neuroscience 8:743-765.
27. Egan MF, Weinberger DR. 1997. Neurobiology of schizophrenia. Curr Opin Neurobiol 7:701-707.
28. Ernfors P, Lee KF, Jaenisch R. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150.
29. Fallon JH, Loughlin SE. 1995. Substantia nigra. In: Paxinos G, editor. The rat nervous system. New York: Academic Press. p 215-237.
30. Fallon JH, Moore RY. 1978. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545-580.
31. Fallon JH, Koziell DA, Moore RY. 1978. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532.
32. Fariñas I, Reichardt LF. 1996. Neurotrophic factors and their receptor: implications of genetic studies. Semin Neurosci 8:133-143.
33. Fariñas I, Wilkinson GA, Backus C, Reichardt L, Patapoutian A. 1998. Characterization of neurotrophin and Trk receptor functions in developing sensory ganglia: direct NT-3 activation of TrkB neurons in vivo. Neuron 21:325-334.
34. Fawcett JP, Aloyz R, McLean JH, Pareek S, Miller FD, McPherson PS, Murphy RA. 1997. Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes. J Biol Chem 272:8837-8840.
35. Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA, McLean JH, Miller FD. 1998. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci 18:2808-2821.
36. Fornai F, Torracca MT, Bassi L, D'Errigo DA, Scalori V, Corsini GU. 1996. Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats. Brain Res 735:349-353.
37. Foster GA. 1994. Ontogeny of catecholaminergic neurons in the central nervous system of mammalian species: general aspects. In: Smeets WJAJ, Reiner A, editors. Phylogeny and development of catecholamine systems in the CNS of vertebrates. Cambridge: Cambridge University Press. p 405-434.
38. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: Academic Press.
39. Fritschy JM, Grzanna R. 1990. Distribution of locus coeruleus axons within the rat brainstem demonstrated by Phaseolus vulgaris leucoagglutinin anterograde tracing in combination with dopamine β-hydroxylase immunofluorescence. J Comp Neurol 293:616-631.
40. Fryer RH, Kaplan DR, Feinstein SC, Radeke MJ, Grayson DR, Kromer LF. 1996. Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol 374:21-40.
41. German DC, Manaye KF. 1993. Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three dimensional reconstruction in the rat. J Comp Neurol 331:297-309.
42. Ghosh A, Carnahan J, Greenberg ME. 1994. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623.
43. Goodman LJ, Valverde J, Lim F, Geschwind MD, Federoff HJ, Geller AI, Hefti F. 1996. Regulated release and polarized localization of brain-derived neurotrophic in hippocampal neurons. Mol Cell Neurosci 7:222-238.
44. Greenberg D, Banarjee SP, Yamamura HI, Snyder SH. 1974. Drugs, neurotransmitters and schizophrenia. Science 184:1243-1253.
45. Guillery RW, Herrup K. 1997. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol 386:2-7.
46. Gundersen HJ. 1992. Stereology: the fast lane between neuroanatomy and brain function - or still only a tightrope? Acta Neurol Scand 137(Suppl): 8-13.
47. Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH. 1991. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J Neurochem 57:479-482.
48. Hafidi A, Moore T, Sanes DH. 1996. Regional distribution of neurotrophin receptors in the developing auditory brainstem. J Comp Neurol 367:454-464.
49. Halliday GM, Tork I. 1986. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J Comp Neurol 252:423-445.
50. Hirsch EC, Graybiel AM, Agid YA. 1988. Melanized DA neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348.
51. Hofer MM, Barde YA. 1988. Brain derived neurotrophic factor prevents neuronal death in vivo. Nature 331:261-262.
52. Hornykiewicz O. 1973. Parkinson's disease: from brain homogenate to treatment. Fed Proc 32:183-190.
53. Hoyle GW, Mercer EH, Palmiter RD, Brinster RL. 1994. Cell-specific expression from the human dopamine β-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements. J Neurosci 14:2455-2463.
54. Hsu SM, Raine L, Fanger H. 1981. The use of antiavidin antibody and avidin-biotin-peroxidase complex immunoperoxidase technics. Am J Clin Pathol 75:734-738.
55. Hyman BT. 1998. Stereology: a practical primer for neuropathology. J Neuropathol Exp Neurol 57:305-310.
56. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
57. Hyman C, Juhasz M, Jackson C. Wright P, Ip NY, Lindsay R. 1994. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurones of the ventral mesencephalon. J Neurosci 14:335-347.
58. Ip NY, Yancopoulos GD. 1996. The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Annu Rev Neurosci 19:491-515.
59. Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, Greene LA, Barbacid M, Yancopoulos GD. 1993. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and non-neuronal cells. Neuron 10:137-149.
60. Jaeger C. 1986. Aromatic L-amino decarboxylase in the rat brain: immunoytochemical localization during prenatal development. Neuroscience 18:121-150.
61. Janec E, Burke RE. 1993. Naturally occurring cell death during postnatal development of the substantia nigra pars compacta of rat. Mol Cell Neurosci 4:30-35.
62. Jenner P, Schapira AH, Marsden CD. 1992. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250.
63. Johnson F, Hohmann SE, DiStefano PS, Bottjer SW. 1997. Neurotrophins suppress apoptosis induced by deafferentation of the avian motor-cortical region. J Neurosci 17:2101-2111.
64. Jones BE, Moore RY. 1977. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127:23-53.
65. Jones KR, Fariñas I, Backus C, Reichardt LF. 1994. Targeted disruption of the BDNF gene perturbs brain sensory neuron development but not motor neuron development. Cell 76:989-999.
66. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. 1991. The trk protoco-oncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-558.
67. Klein R, Parada LF, Boulier F, Barbacid M. 1989. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J 8:3701-3709.
68. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M. 1993. Target disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75:113-122.
69. Knüsel B, Michel PP, Schwaber JS, Hefti F. 1990. Selective and non selective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic growth factor, epidermal growth factor, insulin and the insulin growth factors I and II. J Neurosci 10:558-570.
70. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc Natl Acad Sci USA 88:961-965.
71. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F. 1992. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391-4401.
72. Korsching S. 1993. The neurotrotrophic factor concept: a reexamination. J Neurosci 13:2739-2748.
73. Krieglstein K, Suter-Crazzolara C, Hotten G, Pohl J, Unsicker K. 1995. Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J Neurosci Res 42:724-732.
74. Lauder JM. 1993. Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 16:233-240.
75. Lauder JM, Bloom FE. 1974. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. J Comp Neurol 155:469-482.
76. Lin LH, Doherti DH, Lile JD, Becktesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
77. Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ. 1993. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp Neurol 124:103-118.
78. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. 1994. Neurotrophic factors: from molecule to man. Trends Neurosci 17:182-190.
79. Liu H, Ernfors P, Wu H, Jaenisch R. 1995. Sensory but not motor neuron deficits in mice lacking NT-4 and BDNF. Nature 375:238-241.
80. Marchand R, Poirier LJ. 1983. Isthmic origin of neurons of the rat substantia nigra. Neuroscience 9:373-381.
81. Marien M, Briley M, Colpaert F. 1993. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur J Pharmacol 236:487-489.
82. Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC. 1991. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41:507-523.
83. Mena MA, Casarejos MJ, Gimenez-Gallego G, Garcia de Yebenes J. 1995. Fibroblast growth factors: structure-activity on dopamine neurons in vitro. J Neural Transmiss 9:1-14.
84. Merlio JP, Ernfors P, Jaber M, Persson H. 1992. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51:513-532.
85. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestly JV. 1997. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17:8476-8490.
86. Mowla SJ, Pareek S, Farhadi HF, Petrecca K, Fawcett JP, Seidah NG, Morris SJ, Sossin WS, Murphy RA. 1999. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosci 19:2069-2080.
87. Mufson EJ, Kroin JS, Sobreviela T, Burke MA, Kordower JH, Penn RD, Miller JA. 1994. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Exp Neurol 129:15-26.
88. Nelson EL, Liang C-L, Sinton CM, German DC. 1996. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol 369:361-371.
89. Oo TF, Burke RE. 1997. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res 98:191-196.
90. Parent A. 1986. Comparative neurobiology of the basal ganglia. New York: John Wiley & Sons.
91. Poirier LJ, Giguere M, Marchand R. 1983. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res Bull 11:371-397.
92. Poulsen KT, Armanini MP, Klein RD, Hynes MA, Phillips HS, Rosenthal A. 1994. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13:1245-1252.
93. Sadikot AF, Parent A. 1990. The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study. Neuroscience 36:431-447.
94. Saper CB. 1996. Any way you cut it: a new journal policy for the use of unbiased counting methods. J Comp Neurol 364:5.
95. Sauer H, Fisher W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Björklund A. 1993. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res 626:37-44.
96. Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM. 1994. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321-334.
97. Shen RY, Altar CA, Chiodo LA. 1994. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc Natl Acad Sci USA 91:8920-8924.
98. Snider WD. 1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638.
99. Sobreviela T, Pagcatipunan M, Kroin JS, Mufson EJ. 1996. Retrograde transport of brain-derived neurotrophic factor (BDNF) following infusion in neo-and limbic cortex in rat: relationship to BDNF mRNA expressing neurons. J Comp Neurol 375:417-444.
100. Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J, Burton LE, Stanton BR, Kaplan DR, Hunter T, Nikolics K, Parada LF. 1991. The neurotrophic factors brain-derived neurotrophc factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65:895-903.
101. Spenger C, Hyman C, Studer L, Egli M, Evtouchenko L, Jackson C, Dahl-Jorgensen A, Lindsay RM, Seiler RW. 1995. Effects of BDNF on dopaminergic, serotoninergic and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp Neurol 133:50-63.
102. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and n-metryl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
103. Sterio DC. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127-136.
104. Swanson LW, Hartman BK. 1975. The central adrenergic system: an immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker. J Comp Neurol 163:467-506.
105. Thoenen H. 1991. The changing scene of neurotrophic factors. Trends Neurosci 14:165-170.
106. Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N. 1995. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkey's. Neurosurgery 37:733-741.
107. Verney C, Berger B, Baulac M, Helle KB, Alvarez C. 1984. Dopamine-β hydroxylase-like immunoreactivity in the fetal cerebral cortex of the rat: noradrenergic ascending pathways and terminal fields. Int J Dev Neurosci 2:491-503.
108. von Bartheld CS, Byers ML, William R, Bothwell M. 1996. Anterograde transport of neurotrophins and axo-dendritic transfer in the developing visual system. Nature 379:830-833.
109. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. 1988. The pre-and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum in the rat. Neuroscience 25:857-887.
110. Weibel ER. 1979. Stereological methods. Volume 1, Practical methods for biological morphometry. London: Academic Press.
111. Wichmann T, DeLong MR. 1996. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6:751-758.
112. Wu K, Xu JL, Suen PC, Levine E, Huang YY, Mount HT, Lin SY, Black IB. 1996. Functional trkB neurotrophin receptors are intrinsic components of the adult brain postsynaptic density. Brain Res Mol Brain Res 43:286-290.
113. Yurek DM, Lu W, Hipkens S, Wiegand SJ. 1998. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 137:105-118.
114. Zhou J, Bradford HF, Stern GM. 1994. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res 656:147-156.
115. Zhou J, Bradford HF, Stern GM. 1997. Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. Brain Res Dev Brain Res 100:43-51.